# MOMENTUM 3 Continued Access Protocol

> **NCT02892955** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1685 (actual)

## Conditions studied

- Advanced Refractory Left Ventricular Heart Failure

## Interventions

- **DEVICE:** HeartMate 3 LVAS

## Key facts

- **NCT ID:** NCT02892955
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2020-12
- **Final completion:** 2021-03
- **Target enrollment:** 1685 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02892955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02892955, "MOMENTUM 3 Continued Access Protocol". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02892955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*